1. All Products
  2. ADENOSINE, 3mg/ml, 2ml, vial
Public Pricelist

ADENOSINE, 3mg/ml, 2ml, vial

https://unicat.msf.org/cat/product/40932
NST DINJADEN6V-

Valid Article

Former Code(s): -X DINJZBE0022 DINJZFR0199 DINJADEN6A-
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
12.2 - Antiarrhythmic medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
C01EB10
Anatomical Therapeutic Chemical Classification according to WHOCC
PM
The order of this product needs to be justified and is only acceptable under certain conditions.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
https://www.unicat.msf.org/web/image/product.template/589875/image_1920?unique=8e28bb4

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

ADENOSINE - NST

Therapeutic Action

Antiarrhythmic

Indications

Rapid conversion to a normal sinus rhythm of paroxysmal supraventricular
tachycardias (SVT)

Aid in the diagnosis of narrow complex tachycardias when the origin of the tachycardia is not clearly established.

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Must be given by rapid IV bolus, immediately followed by a rapid flush of 20 ml of 0.9% NaCl.

Posology (adults):

  • Initial dose: 6 mg by rapid IV injection
  • If no reversion to sinus rhythm in 1‐2 minutes: 12 mg by rapid IV injection
  • If no reversion to sinus rhythm in further 1‐2 minutes: 12 mg by rapid IV injection
  • Maximum total dose: 30 mg

Administer only in hospital settings with monitoring and cardiorespiratory resuscitation equipment available for immediate use.

During administration, continuous ECG monitoring is necessary due to the risk of fatal arrhythmias.

Verapamil or diltiazem may be used as alternative if adenosine is contraindicated or in case of supply constraints.

Contact your OC anaesthetist advisor for more details.

Precautions for Use

Contraindicated in patients with:

  • second or third degree Atrio-Ventricular (AV) block
  • bronchial asthma
  • sick sinus syndrome
  • severe hypotension

Storage

  • Bellow 25ºC
  • Do not refrigerate.
  • After opening the vial, use the product immediately. Discard any unused remaining product.